SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024
Impairment Effects on Earnings Per Share [Line Items]
Cash and Cash Equivalents	$ 1,413,794	$ 1,848,295
Cash [Member]
Impairment Effects on Earnings Per Share [Line Items]
Cost	214,394	109,659
Unrealized Gain (Loss)
Fair Value
Cash and Cash Equivalents	214,394	109,659
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Cost	1,199,400	1,738,636
Unrealized Gain (Loss)
Fair Value	1,199,400	1,738,636
Cash and Cash Equivalents	1,199,400	1,738,636
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Cost	1,413,794	1,848,295
Unrealized Gain (Loss)
Fair Value	1,199,400	1,738,636
Cash and Cash Equivalents	$ 1,413,794	$ 1,848,295